Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study

BACKGROUND: Mycophenolic acid (MPA) is widely used as part of immunosuppressive regimens following allograft transplantation. The large pharmacokinetic (PK) and pharmacodynamic (PD) variability and narrow therapeutic range of MPA provide a potential for therapeutic drug monitoring. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremer, Sara, Vethe, Nils T, Rootwelt, Helge, Jørgensen, Pål F, Stenstrøm, Jean, Holdaas, Hallvard, Midtvedt, Karsten, Bergan, Stein
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724496/
https://www.ncbi.nlm.nih.gov/pubmed/19635156
http://dx.doi.org/10.1186/1479-5876-7-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724496/
https://www.ncbi.nlm.nih.gov/pubmed/19635156
http://dx.doi.org/10.1186/1479-5876-7-64

Ejemplares similares